Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
 

 

TTD Drug ID: DAP001128

Drug Information
NameOxybutynin    
SynonymsHSDB 3270; Oxybutynin (USAN/INN); S1754_Selleck; oxybutynin; CID4634; I06-2117; Cystrin; Prestwick0_000287; 4-(Diethylamino)-2-butynyl alpha-phenylcyclohexaneglycolic acid ester; 1508-65-2 (hydrochloride); Oxybutyninum [INN-Latin]; Lopac0_000923; SPBio_002413; LS-28714; Oxybutynin Base; CHEMBL1231; Prestwick3_000287; L000923; transdermal patch; 4-(diethylamino)but-2-ynyl 2-cyclohexyl-2-hydroxy-2-phenylacetate; Ditropan; 5633-20-5; Oxytrol; FT-0082890; Oxibutinina [INN-Spanish]; BPBio1_000214; 4-Diethylamino-2-butinyl alpha-cyclohexylmandelat; NCGC00015767-06; Benzeneacetic acid, alpha-cyclohexyl-alpha-hydroxy-, 4-(diethylamino)-2-butynyl ester; Oxybutinin; Oxybutyninum; Oxybutynine [INN-French]; C07360; 4-(diethylamino)but-2-yn-1-yl cyclohexyl(hydroxy)phenylacetate; UNII-K9P6MC7092; 4-(diethylamino)-2-butynyl-alpha-cyclohexyl-alpha-hydroxybenzeneacetate; Oxibutinina; DB01062; Cyclohexaneglycolic acid, alpha-phenyl-, 4-(diethylamino)-2-butynyl ester; Prestwick1_000287; AC1L1ILV; oxybutynin topical gel; Cyclohexaneglycolic acid, .alpha.-phenyl-, 4-(diethylamino)-2-butynyl ester; D00465; Prestwick2_000287; 4-(diethylamino)-2-butynyl-alpha-phenylcyclohexaneglycolate; Ditropan, Lyrinel XL, Oxytrol, Oxybutynin; 4-Diethylamino-2-butynyl alpha-phenylcyclohexaneglycolate; CCRIS 1923; Oxybutynine; Oxibutyninum; CHEBI:7856; NCGC00089795-02; MolPort-003-849-741; AC-2153; Oxybutynin [USAN:INN:BAN]; Oxytrol (TN); Pollakisu; BRD-A65013509-003-03-8; BSPBio_000194    
Trade NameGelnique; Ditropan; Lyrinel XL; Oxytrol    
CompanyAvenzor Syria    
IndicationUrinary and bladder difficultiesApproved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
   
Therapeutic ClassAnticholinergic Agents    
CAS NumberCAS 5633-20-5
FormularC22H31NO3    
PubChem Compound IDCID 4634.    
PubChem Substance IDSID 9564.    
ChEBI7856;    
SuperDrug ATC IDG04BD04;    
SuperDrug CAS ID005633205;    
TargetMuscarinic acetylcholine receptor M3Antagonist[2]
Ref 1FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (NDA) 017577 To Reference
Ref 2Transdermal oxybutynin. Drugs. 2009;69(3):327-37. doi: 10.2165/00003495-200969030-00008. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

 
   
           
 
Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543